表紙:マルチプレックスアッセイ市場 - タイプ別、製品別、用途別、エンドユーザー別:世界の機会分析と業界予測(2020年~2030年)
市場調査レポート
商品コード
1065604

マルチプレックスアッセイ市場 - タイプ別、製品別、用途別、エンドユーザー別:世界の機会分析と業界予測(2020年~2030年)

Multiplex Assay Market by Type, Product, Application, and End User : Global Opportunity Analysis and Industry Forecast, 2020-2030

出版日: | 発行: Allied Market Research | ページ情報: 英文 245 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.61円
マルチプレックスアッセイ市場 - タイプ別、製品別、用途別、エンドユーザー別:世界の機会分析と業界予測(2020年~2030年)
出版日: 2022年01月24日
発行: Allied Market Research
ページ情報: 英文 245 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のマルチプレックスアッセイの市場規模は、2020年に19億4,049万米ドルとなりました。

同市場は、2021年~2030年にかけて8.3%のCAGRで拡大し、2030年には43億6,632万米ドルに達すると予測されています。

マルチプレックスアッセイ市場は、いくつかの疾患の治療のための医薬品の研究開発活動の増加により、著しい成長を遂げています。これらのアッセイは、研究コストや手作業を減らし、実験や治療の効率を高めるため、臨床試験で使用されています。さらに、従来の方法と比較して、疾患の分析が容易かつ迅速に行えることや、自動化されていることも、同市場の成長に拍車をかけています。しかし、高い設備投資と熟練労働者の不足が市場の成長を阻害する主な要因となっています。

当レポートでは、世界のマルチプレックスアッセイ市場について調査し、市場の概要とともに、タイプ別、製品別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
  • ポーターのファイブフォース分析
  • 主要参入企業の位置づけ、2020年
  • 市場力学
    • 促進要因
      • 研究開発活動と政府資金の増加
      • 運用コストを削減するためのマルチプレックスアッセイの採用急増
      • 個別化医療の導入拡大
    • 抑制要因
      • 熟練労働者/ヘルスケア専門家の不足
    • 市場の機会
      • 新興国におけるさまざまな成長の機会
  • マルチプレックスアッセイ市場におけるCOVID-19の影響分析

第4章 マルチプレックスアッセイ市場:タイプ別

  • 概要
    • 市場規模と予測
  • タンパク質ベースのマルチプレックスアッセイ
  • 核酸ベースのマルチプレックスアッセイ
  • その他のマルチプレックスアッセイ

第5章 マルチプレックスアッセイ市場:製品別

  • 概要
    • 市場規模と予測
  • 試薬と消耗品
  • 装置とアクセサリー
  • ソフトウェアとサービス

第6章 マルチプレックスアッセイ市場:用途別

  • 概要
    • 市場規模と予測
  • 臨床診断
  • 研究開発
  • コンパニオン診断

第7章 マルチプレックスアッセイ市場:エンドユーザー別

  • 概要
    • 市場規模と予測
  • 病院
  • 臨床検査室
  • 研究機関
  • 製薬会社・バイオテクノロジー企業

第8章 マルチプレックスアッセイ市場:地域別

  • 概要
    • 市場規模と予測
  • 北米
    • 主要な市場動向、成長促進要因、および機会
    • 市場規模と予測:国別
      • 米国
      • カナダ
      • メキシコ
    • 北米の市場規模と予測:タイプ別
    • 北米の市場規模と予測:製品別
    • 北米の市場規模と予測:用途別
    • 北米の市場規模と予測:エンドユーザー別
  • 欧州
    • 主要な市場動向、成長促進要因、および機会
    • 市場規模と予測:国別
      • ドイツ
      • フランス
      • 英国
      • イタリア
      • スペイン
      • その他
    • 欧州の市場規模と予測:タイプ別
    • 欧州の市場規模と予測:製品別
    • 欧州の市場規模と予測:用途別
    • 欧州の市場規模と予測:エンドユーザー別
  • アジア太平洋
    • 主要な市場動向、成長促進要因、および機会
    • 市場規模と予測:国別
      • 日本
      • 中国
      • オーストラリア
      • インド
      • その他
    • アジア太平洋の市場規模と予測:タイプ別
    • アジア太平洋の市場規模と予測:製品別
    • アジア太平洋の市場規模と予測:用途別
    • アジア太平洋の市場規模と予測:エンドユーザー別
  • ラテンアメリカ、中東、アフリカ
    • 主要な市場動向、成長促進要因、および機会
    • 市場規模と予測:国別
      • ブラジル
      • サウジアラビア
      • 南アフリカ
      • その他
    • ラテンアメリカ、中東、アフリカの市場規模と予測:タイプ別
    • ラテンアメリカ、中東、アフリカの市場規模と予測:製品別
    • ラテンアメリカ、中東、アフリカの市場規模と予測:用途別
    • ラテンアメリカ、中東、アフリカの市場規模と予測:エンドユーザー別

第9章 企業プロファイル

  • ABCAM PLC.
  • BECTON, DICKINSON, AND COMPANY(BD BIOSCIENCES)
  • MESO SCALE DIAGNOSTICS LLC
  • SEEGENE INC.
  • BIO-RAD LABORATORIES, INC.
  • ILLUMINA, INC.
  • QIAGEN N.V.
  • THERMO FISHER SCIENTIFIC, INC.
  • LUMINEX CORPORATION
  • RANDOX LABORATORIES LTD.
図表

LIST OF TABLES

  • TABLE 01.MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 02.MULTIPLEX ASSAY MARKET FOR PROTEIN BASED MULTIPLEX ASSAYS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 03.MULTIPLEX ASSAY MARKET FOR NUCLEIC ACID-BASED MULTIPLEX ASSAY, BY REGION, 2020-2030 ($MILLION)
  • TABLE 04.MULTIPLEX ASSAY MARKET FOR OTHER MULTIPLEX ASSAYS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 05.MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 06.MULTIPLEX ASSAY MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 07.MULTIPLEX ASSAY MARKET FOR INSTRUMENTS & ACCESSORIES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 08.MULTIPLEX ASSAY MARKET FOR SOFTWARE & SERVICES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 09.MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 10.MULTIPLEX ASSAY MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 11.MULTIPLEX ASSAY MARKET FOR RESEARCH AND DEVELOPMENT, BY REGION, 2020-2030 ($MILLION)
  • TABLE 12.MULTIPLEX ASSAY MARKET FOR COMPANION DIAGNOSTICS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 13.MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 14.MULTIPLEX ASSAY MARKET FOR HOSPITALS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 15.MULTIPLEX ASSAY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 16.MULTIPLEX ASSAY MARKET FOR RESEARCH INSTITUTES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 17.MULTIPLEX ASSAY MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 18.MULTIPLEX ASSAY MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 19.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 20.U.S. MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 21.U.S. MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 22.U.S. MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 23.U.S. MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 24.CANADA MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 25.CANADA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 26.CANADA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 27.CANADA MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 28.MEXICO MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 29.MEXICO MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 30.MEXICO MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 31.MEXICO MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 32.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 33.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 34.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 35.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 36.EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 37.GERMANY MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 38.GERMANY MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 39.GERMANY MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 40.GERMANY MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 41.FRANCE MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 42.FRANCE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 43.FRANCE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 44.FRANCE MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 45.UK MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 46.UK MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 47.UK MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 48.UK MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 49.ITALY MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 50.ITALY MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 51.ITALY MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 52.ITALY MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 53.SPAIN MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 54.SPAIN MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 55.SPAIN MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 56.SPAIN MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 57.REST OF EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 58.REST OF EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 59.REST OF EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 60.REST OF EUROPE MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 61.EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 62.EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 63.EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 64.EUROPE MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 65.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 66.JAPAN MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 67.JAPAN MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 68.JAPAN MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 69.JAPAN MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 70.CHINA MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 71.CHINA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 72.CHINA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 73.CHINA MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 74.AUSTRALIA MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 75.AUSTRALIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 76.AUSTRALIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 77.AUSTRALIA MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 78.INDIA MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 79.INDIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 80.INDIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 81.INDIA MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 82.REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 83.REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 84.REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 85.REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 86.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 87.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 88.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 89.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 90.LAMEA MULTIPLEX ASSAY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 91.BRAZIL MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 92.BRAZIL MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 93.BRAZIL MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 94.BRAZIL MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 95.SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 96.SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 97.SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 98.SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 99.SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 100.SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 101.SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 102.SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 103.REST OF LAMEA MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 104.REST OF LAMEA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 105.REST OF LAMEA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 106.REST OF LAMEA MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 107.LAMEA MULTIPLEX ASSAY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 108.LAMEA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 109.LAMEA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 110.LAMEA MULTIPLEX ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 111.ABCAM PLC.: COMPANY SNAPSHOT
  • TABLE 112.ABCAM PLC.: OPERATING SEGMENTS
  • TABLE 113.ABCAM PLC.: PRODUCT PORTFOLIO
  • TABLE 114.ABCAM PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 116.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 117.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 118.BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119.MESO SCALE DIAGNOSTICS: COMPANY SNAPSHOT
  • TABLE 120.MESO SCALE DIAGNOSTICS: OPERATING SEGMENTS
  • TABLE 121.MESO SCALE DIAGNOSTICS: PRODUCT PORTFOLIO
  • TABLE 122.SEEGENE: COMPANY SNAPSHOT
  • TABLE 123.SEEGENE: OPERATING SEGMENTS
  • TABLE 124.SEEGENE: PRODUCT PORTFOLIO
  • TABLE 125.BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • TABLE 126.BIO-RAD LABORATORIES: OPERATING SEGMENTS
  • TABLE 127.BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 128.BIO-RAD LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129.ILLUMINA, INC.: COMPANY SNAPSHOT
  • TABLE 130.ILLUMINA INC.: OPERATING SEGMENTS
  • TABLE 131.ILLUMINA, INC.: PRODUCT PORTFOLIO
  • TABLE 132.ILLUMINA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 133.QIAGEN: COMPANY SNAPSHOT
  • TABLE 134.QIAGEN NV: OPERATING SEGMENTS
  • TABLE 135.QIAGEN NV: PRODUCT PORTFOLIO
  • TABLE 136.QIAGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137.THERMO FISHER: COMPANY SNAPSHOT
  • TABLE 138.THERMO FISHER: OPERATING SEGMENTS
  • TABLE 139.THERMO FISHER: PRODUCT PORTFOLIO
  • TABLE 140.THERMO FISHER: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 141.LUMINEX CORPORATION: COMPANY SNAPSHOT
  • TABLE 142.LUMINEX CORPORATION: OPERATING SEGMENTS
  • TABLE 143.LUMINEX CORPORATION: PRODUCT PORTFOLIO
  • TABLE 144.LUMINEX CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 145.RANDOX: COMPANY SNAPSHOT
  • TABLE 146.RANDOX OPERATING SEGMENTS
  • TABLE 147.RANDOX: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.MULTIPLEX ASSAY MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS, 2020
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2019-2021
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021
  • FIGURE 06.LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 08.MODERATE THREAT OF SUBSTITUTES
  • FIGURE 09.LOW THREAT OF NEW ENTRANTS
  • FIGURE 10.MODERATE COMPETITIVE RIVALRY
  • FIGURE 11.TOP PLAYER POSITIONING, 2020
  • FIGURE 12.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR PROTEIN BASED MULTIPLEX ASSAYS, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 13.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR NUCLEIC ACID-BASED MULTIPLEX ASSAY, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 14.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR OTHER MULTIPLEX ASSAYS, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 15.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR REAGENTS AND CONSUMABLES, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 16.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 17.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 18.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 19.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 20.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR COMPANION DIAGNOSTICS, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 21.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR HOSPITALS, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 22.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 23.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 24.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 25.ABCAM PLC.: NET SALES, 2018-2020 ($ MILLION)
  • FIGURE 26.ABCAM PLC. REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 27.BECTON, DICKINSON AND COMPANY: NET SALES, 2018-2020 ($ MILLION)
  • FIGURE 28.BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 29.BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 30.BIO-RAD LABORATORIES: NET SALES, 2018-2020 ($ MILLION)
  • FIGURE 31.BIO-RAD LABORATORIES: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 32.BIO-RAD LABORATORIES: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 33.ILLUMINA, INC.: NET SALES, 2018-2020 ($ MILLION)
  • FIGURE 34.ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 35.ILLUMINA, INC.: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 36.QIAGEN NV: NET SALES, 2020-2030 ($ MILLION)
  • FIGURE 37.QIAGEN: REVENUE SHARE BY PRODUCT, 2020 (%)
  • FIGURE 38.QIAGEN: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 39.THERMO FISHER: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 40.THERMO FISHER: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 41.THERMO FISHER: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 42.LUMINEX CORPORATION: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 43.LUMINEX CORPORATION: REVENUE SHARE BY REGION, 2020 (%)
目次
Product Code: LI_171921 / A01591

The global multiplex assay market was valued at $1,940.49 million in 2020, and is projected to reach $4,366.32 million by 2030, registering a CAGR of 8.3% from 2021 to 2030.

The multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others.

The multiplex assays market is witnessing tremendous growth owing to increase in R&D activities in pharmaceuticals for the treatment of several diseases. These assays are used in clinical trials as they decrease the cost of research & manual labor and increase the efficiency of experiments and therapies. In addition, they offer easier & faster analysis of diseases, and automated as compared to conventional methods, thus fueling the market growth. However, high capital investment and dearth of skilled labors are the major factors that hinder the market growth.

The global multiplex assays market in this report is studied based on type, product, application, end user, and region. On the basis of type, the market is divided protein based multiplex assays, nucleic acid-based multiplex assay, and other multiplex assays. By product, the market is classified into reagents & consumables, instruments & accessories, software & services.

The applications covered in the study include clinical diagnostics, research & development, and companion diagnostics. As per end user, the market is segregated into hospitals, clinical laboratories, research institutes, and pharmaceutical & biotechnology companies. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major factors driving the market are increasing use of multiplex assays in companion diagnostics, increasing advantages over singleplex and traditional assays, increasing incidence of chronic and infectious diseases, and growing awareness about early disease diagnosis. In addition, growing adoption of personalized medicine, and a wide range of advantages of multiplex assays over traditional assays are positively impacting the growth of the multiplex assay market.

However, dearth of skilled professionals is expected to create hindrances for the growth of the multiplex assay market. Moreover, high procurement and operational costs along with the cumbersome and complex nature of multiplex assay instruments remain a significant hurdle in the multiplex assay market.

Increasing validation of the biomarkers in molecular and protein diagnostics, along with the rising need of the high-throughput and automated systems which are creating lucrative opportunities in the multiplex assay market.

Region wise, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the multiplex assays market in 2020, and is expected to retain its dominance throughout the forecast period. This is primarily attributed to the increase in government funds for the detection of new biomarkers, rise in R&D activates of new drugs and diagnosis & treatment options, as well as surge in prevalence of chronic diseases such as cancer and strokes.

The major players operating in the global multiplex assays market are Luminex Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Becton, Dickinson and Company, Abcam PLC, Seegene Inc., Meso Scale Diagnostics LLC, and Randox Laboratories Ltd. These players adopted product launch, collaboration, and merger & acquisition as their key developmental strategies.

KEY BENEFITS FOR STAKEHOLDERS

  • The report provides in-depth analysis of the global multiplex assay market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global multiplex assay market growth.

KEY MARKET SEGMENTS

  • # By Type
  • ##Protein-Based Multiplex Assays
  • ##Nucleic Acid-Based Multiplex Assay
  • ##Other multiplex Assays
  • # By Product
  • ##Reagents & Consumables
  • ##Instruments & Accessories
  • ##Software & Services
  • #By application
  • ##Clinical Diagnostics
  • ##Research & Development
  • ##Companion Diagnostics
  • #By End Users
  • ##Hospitals
  • ##Clinical Laboratories
  • ##Research Institutes
  • ##Pharmaceuticals & Biotechnological Companies
  • #By Region
  • ##North America
  • ###U.S.
  • ###Canada
  • ###Mexico
  • ##Europe
  • ###Germany
  • ###France
  • ###UK
  • ###Italy
  • ###Spain
  • ###Rest of Europe
  • ##Asia-Pacific
  • ###Japan
  • ###China
  • ###Australia
  • ###India
  • ###South Korea
  • ###Rest of Asia-Pacific
  • ##LAMEA
  • ###Brazil
  • ###Saudi Arabia
  • ###South Africa
  • ###Rest of LAMEA

List of key players profiled in the report:

  • Luminex Corporation
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • QIAGEN N.V.
  • Becton, Dickinson and Company
  • Abcam PLC
  • Seegene Inc.
  • Meso Scale Diagnostics LLC
  • Randox Laboratories Ltd.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Porter's five force analysis
  • 3.4.Top player positioning, 2020
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Increase in R&D activities & government funding
      • 3.5.1.2.Surge in adoption of multiplex assays to reduce operation costs
      • 3.5.1.3.Rise in adoption of personalized medicines
    • 3.5.2.Restraint
      • 3.5.2.1.Lack of skilled labor/healthcare professionals
    • 3.5.3.Opportunity
      • 3.5.3.1.Various growth opportunities in emerging economies
  • 3.6.COVID-19 impact analysis on multiplex assay market

CHAPTER 4:MULTIPLEX ASSAY MARKET, BY TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Protein based multiplex assays
    • 4.2.1.Key market trends and opportunities
    • 4.2.2.Market size and forecast, by region
    • 4.2.3.Market analysis, by country
  • 4.3.Nucleic Acid-Based Multiplex Assay
    • 4.3.1.Key market trends and opportunities
    • 4.3.2.Market size and forecast, by region
    • 4.3.3.Market analysis, by country
  • 4.4.Other multiplex assays
    • 4.4.1.Key market trends and opportunities
    • 4.4.2.Market size and forecast, by region
    • 4.4.3.Market analysis, by country

CHAPTER 5:MULTIPLEX ASSAY MARKET, BY PRODUCT

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Reagents and Consumables
    • 5.2.1.Key market trends and opportunities
    • 5.2.2.Market size and forecast, by region
    • 5.2.3.Market analysis, by country
  • 5.3.Instruments and Accessories
    • 5.3.1.Key market trends and opportunities
    • 5.3.2.Market size and forecast, by region
    • 5.3.3.Market analysis, by country
  • 5.4.Software & Services
    • 5.4.1.Key market trends and opportunities
    • 5.4.2.Market size and forecast, by region
    • 5.4.3.Market analysis, by country

CHAPTER 6:MULTIPLEX ASSAY MARKET, BY APPLICATION

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Clinical Diagnostics
    • 6.2.1.Market size and forecast, by region
    • 6.2.2.Market analysis, by country
  • 6.3.Research and development
    • 6.3.1.Market size and forecast, by region
    • 6.3.2.Market analysis, by country
  • 6.4.Companion Diagnostics
    • 6.4.1.Market size and forecast, by region
    • 6.4.2.Market analysis, by country

CHAPTER 7:MULTIPLEX ASSAY MARKET, BY END USER

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.Hospitals
    • 7.2.1.Market size and forecast, by region
    • 7.2.2.Market analysis, by country
  • 7.3.Clinical Laboratories
    • 7.3.1.Market size and forecast, by region
    • 7.3.2.Market analysis, by country
  • 7.4.Research Institutes
    • 7.4.1.Market size and forecast, by region
    • 7.4.2.Market analysis, by country
  • 7.5.Pharmaceutical & biotechnology companies
    • 7.5.1.Market size and forecast, by region
    • 7.5.2.Market analysis, by country

CHAPTER 8:MULTIPLEX ASSAY MARKET, BY REGION

  • 8.1.Overview
    • 8.1.1.Market size and forecast
  • 8.2.North America
    • 8.2.1.Key market trends, growth factors, and opportunities
    • 8.2.2.Market size and forecast, by country
      • 8.2.2.1.U.S.
      • 8.2.2.1.1.U.S. Multiplex Assay Market, by type
      • 8.2.2.1.2.U.S. Multiplex Assay Market, by product
      • 8.2.2.1.3.U.S. Multiplex Assay Market, by application
      • 8.2.2.1.4.U.S. Multiplex Assay Market, by end user
      • 8.2.2.2.Canada
      • 8.2.2.2.1.Canada Multiplex Assay Market, by type
      • 8.2.2.2.2.Canada Multiplex Assay Market, by product
      • 8.2.2.2.3.Canada Multiplex Assay Market, by application
      • 8.2.2.2.4.Canada Multiplex Assay Market, by end user
      • 8.2.2.3.Mexico
      • 8.2.2.3.1.Mexico Multiplex Assay Market, by type
      • 8.2.2.3.2.Mexico Multiplex Assay Market, by product
      • 8.2.2.3.3.Mexico Multiplex Assay Market, by application
      • 8.2.2.3.4.Mexico Multiplex Assay Market, by end user
    • 8.2.3.North America market size and forecast, by type
    • 8.2.4.North America market size and forecast, by product
    • 8.2.5.North America market size and forecast, by application
    • 8.2.6.North America market size and forecast, by end user
  • 8.3.Europe
    • 8.3.1.Key market trends, growth factors, and opportunities
    • 8.3.2.Market size and forecast, by country
      • 8.3.2.1.Germany
      • 8.3.2.1.1.Germany Multiplex Assay Market, by type
      • 8.3.2.1.2.Germany Multiplex Assay Market, by product
      • 8.3.2.1.3.Germany Multiplex Assay Market, by application
      • 8.3.2.1.4.Germany Multiplex Assay Market, by end user
      • 8.3.2.2.France
      • 8.3.2.2.1.France Multiplex Assay Market, by type
      • 8.3.2.2.2.France Multiplex Assay Market, by product
      • 8.3.2.2.3.France Multiplex Assay Market, by application
      • 8.3.2.2.4.France Multiplex Assay Market, by end user
      • 8.3.2.3.UK
      • 8.3.2.3.1.UK Multiplex Assay Market, by type
      • 8.3.2.3.2.UK Multiplex Assay Market, by product
      • 8.3.2.3.3.UK Multiplex Assay Market, by application
      • 8.3.2.3.4.UK Multiplex Assay Market, by end user
      • 8.3.2.4.Italy
      • 8.3.2.4.1.Italy Multiplex Assay Market, by type
      • 8.3.2.4.2.Italy Multiplex Assay Market, by product
      • 8.3.2.4.3.Italy Multiplex Assay Market, by application
      • 8.3.2.4.4.Italy Multiplex Assay Market, by end user
      • 8.3.2.5.Spain
      • 8.3.2.5.1.Spain Multiplex Assay Market, by type
      • 8.3.2.5.2.Spain Multiplex Assay Market, by product
      • 8.3.2.5.3.Spain Multiplex Assay Market, by application
      • 8.3.2.5.4.Spain Multiplex Assay Market, by end user
      • 8.3.2.6.Rest of Europe
      • 8.3.2.6.1.Rest of Europe Multiplex Assay Market, by type
      • 8.3.2.6.2.Rest of Europe Multiplex Assay Market, by product
      • 8.3.2.6.3.Rest of Europe Multiplex Assay Market, by application
      • 8.3.2.6.4.Rest of Europe Multiplex Assay Market, by end user
    • 8.3.3.Europe market size and forecast, by type
    • 8.3.4.Europe market size and forecast, by product
    • 8.3.5.Europe market size and forecast, by application
    • 8.3.6.Europe market size and forecast, by end user
  • 8.4.Asia-Pacific
    • 8.4.1.Key market trends, growth factors, and opportunities
    • 8.4.2.Market size and forecast, by country
      • 8.4.2.1.Japan
      • 8.4.2.1.1.Japan Multiplex Assay Market, by type
      • 8.4.2.1.2.Japan Multiplex Assay Market, by product
      • 8.4.2.1.3.Japan Multiplex Assay Market, by application
      • 8.4.2.1.4.Japan Multiplex Assay Market, by end user
      • 8.4.2.2.China
      • 8.4.2.2.1.China Multiplex Assay Market, by type
      • 8.4.2.2.2.China Multiplex Assay Market, by product
      • 8.4.2.2.3.China Multiplex Assay Market, by application
      • 8.4.2.2.4.China Multiplex Assay Market, by end user
      • 8.4.2.3.Australia
      • 8.4.2.3.1.Australia Multiplex Assay Market, by type
      • 8.4.2.3.2.Australia Multiplex Assay Market, by product
      • 8.4.2.3.3.Australia Multiplex Assay Market, by application
      • 8.4.2.3.4.Australia Multiplex Assay Market, by end user
      • 8.4.2.4.India
      • 8.4.2.4.1.India Multiplex Assay Market, by type
      • 8.4.2.4.2.India Multiplex Assay Market, by product
      • 8.4.2.4.3.India Multiplex Assay Market, by application
      • 8.4.2.4.4.India Multiplex Assay Market, by end user
      • 8.4.2.5.Rest of Asia-Pacific
      • 8.4.2.5.1.Rest of Asia-Pacific Multiplex Assay Market, by type
      • 8.4.2.5.2.Rest of Asia-Pacific Multiplex Assay Market, by product
      • 8.4.2.5.3.Rest of Asia-Pacific Multiplex Assay Market, by application
      • 8.4.2.5.4.Rest of Asia-Pacific Multiplex Assay Market, by end user
    • 8.4.3.Asia-Pacific market size and forecast, by type
    • 8.4.4.Asia-Pacific market size and forecast, by product
    • 8.4.5.Asia-Pacific market size and forecast, by application
    • 8.4.6.Asia-Pacific market size and forecast, by end user
  • 8.5.LAMEA
    • 8.5.1.Key market trends, growth factors, and opportunities
    • 8.5.2.Market size and forecast, by country
      • 8.5.2.1.Brazil
      • 8.5.2.1.1.Brazil Multiplex Assay Market, by type
      • 8.5.2.1.2.Brazil Multiplex Assay Market, by product
      • 8.5.2.1.3.Brazil Multiplex Assay Market, by application
      • 8.5.2.1.4.Brazil Multiplex Assay Market, by end user
      • 8.5.2.2.Saudi Arabia
      • 8.5.2.2.1.Saudi Arabia Multiplex Assay Market, by type
      • 8.5.2.2.2.Saudi Arabia Multiplex Assay Market, by product
      • 8.5.2.2.3.Saudi Arabia Multiplex Assay Market, by application
      • 8.5.2.2.4.Saudi Arabia Multiplex Assay Market, by end user
      • 8.5.2.3.South Africa
      • 8.5.2.3.1.South Africa Multiplex Assay Market, by type
      • 8.5.2.3.2.South Africa Multiplex Assay Market, by product
      • 8.5.2.3.3.South Africa Multiplex Assay Market, by application
      • 8.5.2.3.4.South Africa Multiplex Assay Market, by end user
      • 8.5.2.4.Rest of LAMEA
      • 8.5.2.4.1.Rest of LAMEA Multiplex Assay Market, by type
      • 8.5.2.4.2.Rest of LAMEA Multiplex Assay Market, by product
      • 8.5.2.4.3.Rest of LAMEA Multiplex Assay Market, by application
      • 8.5.2.4.4.Rest of LAMEA Multiplex Assay Market, by end user
    • 8.5.3.LAMEA market size and forecast, by type
    • 8.5.4.LAMEA market size and forecast, by product
    • 8.5.5.LAMEA market size and forecast, by application
    • 8.5.6.LAMEA market size and forecast, by end user

CHAPTER 9:COMPANY PROFILES

  • 9.1.ABCAM PLC.
    • 9.1.1.Company overview
    • 9.1.2.Company snapshot
    • 9.1.3.Operating business segments
    • 9.1.4.Product portfolio
    • 9.1.5.Business performance
    • 9.1.6.Key strategic moves and developments
  • 9.2.BECTON, DICKINSON, AND COMPANY (BD BIOSCIENCES)
    • 9.2.1.Company overview
    • 9.2.2.Company snapshot
    • 9.2.3.Operating business segments
    • 9.2.4.Product portfolio
    • 9.2.5.Business performance
    • 9.2.6.Key strategic moves and developments
  • 9.3.MESO SCALE DIAGNOSTICS LLC
    • 9.3.1.Company overview
    • 9.3.2.Company snapshot
    • 9.3.3.Operating business segments
    • 9.3.4.Product portfolio
  • 9.4.SEEGENE INC.
    • 9.4.1.Company overview
    • 9.4.2.Company snapshot
    • 9.4.3.Operating business segments
    • 9.4.4.Product portfolio
  • 9.5.BIO-RAD LABORATORIES, INC.
    • 9.5.1.Company overview
    • 9.5.2.Company snapshot
    • 9.5.3.Operating business segments
    • 9.5.4.Product portfolio
    • 9.5.5.Business performance
    • 9.5.6.Key strategic moves and developments
  • 9.6.ILLUMINA, INC.
    • 9.6.1.Company overview
    • 9.6.2.Company snapshot
    • 9.6.3.Operating business segments
    • 9.6.4.Product portfolio
    • 9.6.5.Business performance
    • 9.6.6.Key strategic moves and developments
  • 9.7.QIAGEN N.V.
    • 9.7.1.Company overview
    • 9.7.2.Company snapshot
    • 9.7.3.Operating business segments
    • 9.7.4.Product portfolio
    • 9.7.5.Business performance
    • 9.7.6.Key strategic moves and developments
  • 9.8.THERMO FISHER SCIENTIFIC, INC.
    • 9.8.1.Company overview
    • 9.8.2.Company snapshot
    • 9.8.3.Operating business segments
    • 9.8.4.Product portfolio
    • 9.8.5.Business performance
    • 9.8.6.Key strategic moves and developments
  • 9.9.LUMINEX CORPORATION
    • 9.9.1.Company overview
    • 9.9.2.Company snapshot
    • 9.9.3.Operating business segments
    • 9.9.4.Product portfolio
    • 9.9.5.Business performance
    • 9.9.6.Key strategic moves and developments
  • 9.10.RANDOX LABORATORIES LTD.
    • 9.10.1.Company overview
    • 9.10.2.Company snapshot
    • 9.10.3.Operating business segments
    • 9.10.4.Product portfolio